Mural Oncology Statistics Share Statistics Mural Oncology has 17.32M
shares outstanding. The number of shares has increased by 1.36%
in one year.
Shares Outstanding 17.32M Shares Change (YoY) 1.36% Shares Change (QoQ) 0.24% Owned by Institutions (%) 48.9% Shares Floating 12.67M Failed to Deliver (FTD) Shares 400 FTD / Avg. Volume 0.16%
Short Selling Information The latest short interest is 253.65K, so 1.47% of the outstanding
shares have been sold short.
Short Interest 253.65K Short % of Shares Out 1.47% Short % of Float 1.47% Short Ratio (days to cover) 3.05
Valuation Ratios The PE ratio is -0.42 and the forward
PE ratio is -5.28.
Mural Oncology's PEG ratio is
0.01.
PE Ratio -0.42 Forward PE -5.28 PS Ratio 0 Forward PS 3.5 PB Ratio 0.39 P/FCF Ratio -0.42 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Mural Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.84,
with a Debt / Equity ratio of 0.06.
Current Ratio 5.84 Quick Ratio 5.84 Debt / Equity 0.06 Debt / EBITDA -0.06 Debt / FCF -0.06 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.11M Employee Count 116 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -34.6% in the
last 52 weeks. The beta is 3.04, so Mural Oncology's
price volatility has been higher than the market average.
Beta 3.04 52-Week Price Change -34.6% 50-Day Moving Average 2.24 200-Day Moving Average 2.93 Relative Strength Index (RSI) 51.11 Average Volume (20 Days) 252,257
Income Statement
Revenue n/a Gross Profit -3.51M Operating Income -138.26M Net Income -128.51M EBITDA -125M EBIT -128.51M Earnings Per Share (EPS) -7.58
Full Income Statement Balance Sheet The company has 115.46M in cash and 8.02M in
debt, giving a net cash position of 107.44M.
Cash & Cash Equivalents 115.46M Total Debt 8.02M Net Cash 107.44M Retained Earnings -159.37M Total Assets 87.56M Working Capital 53.14M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -128.54M
and capital expenditures -92K, giving a free cash flow of -128.64M.
Operating Cash Flow -128.54M Capital Expenditures -92K Free Cash Flow -128.64M FCF Per Share -7.59
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
